Nitiloop Ltd.: Clinical Trials

5 trials sponsored by Nitiloop Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Unknown 1

Follow Nitiloop Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cohort B of the Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter
NovaCross - Coronary Occlusion
Not applicableUnknownNitiloop Ltd.602018-11-012018-11-06
Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter
NovaCross™ Chronic Total Occlusion micro-catheter - Coronary Occlusion
Not applicableCompletedNitiloop Ltd.402018-10-012019-12-03
A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions
NovaCross - Chronic Total Occlusion
Not applicableCompletedNitiloop Ltd.152017-02-012021-04-28
A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions
NovaCross - Chronic Total Occlusion of Coronary Artery
Not applicableCompletedNitiloop Ltd.1452015-05-172017-08-17
A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).
NovaCross™ microcatheter - Chronic Total Occlusion
Not applicableCompletedNitiloop Ltd.142015-02-012016-09-21

Conditions studied

Coronary Occlusion (2)

Countries

Poland (4)  ·  United States (2)  ·  Israel (1)  ·  United Kingdom (1)

Top investigators

Simon Walsh, MD (3)  ·  Chanan Schneider (1)  ·  Chanan Schneider, Mr. (1)